Chemed Q3 revenue down 2.3% to $526M; raises 2022 adjusted EPS guidance to $19.60-$19.70

CHEMED CORP

2022-Q3 EPS reported $12.41 revenue$1,588,309,000

GAAP diluted EPS of $3.78; adjusted diluted EPS of $4.74, down 6.3% YoY.
VITAS net revenue fell 6.6% to $297M; ADC down 4.4% to 17,242; admissions down 16.6%.
Roto-Rooter revenue rose 3.9% to $230M; adjusted EBITDA margin improved 50bps to 30.2%.
Company repurchased 50,000 shares for $23.9M at avg cost $477.68; $101M authorization remaining.
2022 adjusted EPS guidance raised to $19.60-$19.70 from $19.30-$19.50; VITAS revenue forecast down 4.5%-5%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CHEMED CORP reported third quarter ended September 30, 2022 results: revenue $526 million, EPS $3.78. Guidance raised.

Period: third quarter ended September 30, 2022
Revenue: $526 million
EPS: $3.78
Guidance: raised
Result: reported results

Exact text from the filing

Consolidated operating results: · Revenue declined 2.3% to $526 million · GAAP Diluted Earnings-per-Share (EPS) of $3.78 · Adjusted Diluted EPS of $4.74, a decline of 6.3%

View on SEC.gov

Browse all earnings releases →

CHEMED CORP filing history →

Source: SEC EDGAR

accession 0001562762-22-000404

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.